Journal of the American Academy of Dermatology

Diseases, Conditions, Syndromes

Azathioprine may benefit pediatric atopic dermatitis

(HealthDay) -- For pediatric patients with refractory atopic dermatitis (AD), oral azathioprine is associated with clinical improvement, and measurement of thiopurine methyltransferase (TPMT) activity seems useful for monitoring ...

Oncology & Cancer

Racial differences seen in time to treatment for melanoma

(HealthDay)—Black patients are more likely to experience a longer delay from diagnosis to surgery versus white patients with melanoma, according to a study recently published in the Journal of the American Academy of Dermatology.

Diseases, Conditions, Syndromes

Certolizumab looks promising for moderate-to-severe psoriasis

(HealthDay)—Twice-weekly certolizumab biologic appears to be both safe and effective for the treatment of moderate-to-severe chronic plaque psoriasis, according to a study published online April 13 in the Journal of the ...

Diseases, Conditions, Syndromes

Psoriasis linked to higher risk for thyroid disease

(HealthDay)—Psoriasis is associated with an increased risk for thyroid disease among U.S. adults, according to research published online March 16 in the Journal of the American Academy of Dermatology.

Psychology & Psychiatry

Depression up in pediatric, adult hidradenitis suppurativa patients

(HealthDay)—The prevalence of depression is increased among pediatric and adult patients with hidradenitis suppurativa (HS), according to a study published in the January issue of the Journal of the American Academy of ...

Health

Potent, unregulated steroid creams readily available in U.S.

(HealthDay)—Potent prescription-strength topical corticosteroids without a prescription (PSTCw/oP) are readily available in many U.S. cities, according to a letter to the editor published in the February issue of the Journal ...

Diseases, Conditions, Syndromes

Sustained use of oxymetazoline cream efficacious for rosacea

(HealthDay)—Oxymetazoline is safe and effective for the treatment of moderate-to-severe persistent erythema of rosacea, according to a study published in the June issue of the Journal of the American Academy of Dermatology.

page 14 from 25